Healthcare & Life Sciences
BaroFold
United States
About
BaroFold develops a pressure-enabled protein manufacturing technology (PreEMT™) to modify and produce protein therapeutics, improving the tolerability, efficacy, and safety of protein-based drugs for biopharma companies and research institutions.
Explore BaroFold's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.